De Lisle Partners’s Nephros NEPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-17,400
Closed -$62.1K – 188
2026
Q2
$62.1K Sell
17,400
-7,600
-30% -$24.7K 0.01% 178
2026
Q1
$74.5K Hold
25,000
– – 0.01% 173
2025
Q4
$122K Buy
+25,000
New +$128K 0.02% 169

Other funds holding NEPH

De Lisle Partners's NEPH Position: Q3 2026 in Review

De Lisle Partners sold out of Nephros (NEPH) in Q3 2026, closing a stake of 17,400 shares — an estimated $62.1K sold.

De Lisle Partners first reported a position in NEPH in Q4 2025 and held it in 3 quarters. The position peaked at $122K in Q4 2025. 36 funds tracked by Wall St. Rank hold NEPH as of Q3 2026.

  • De Lisle Partners reported no remaining Nephros position as of Q3 2026 after selling out during the quarter.
  • De Lisle Partners sold 17,400 Nephros shares in Q3 2026, an estimated $62.1K.
  • De Lisle Partners first reported a position in Nephros in Q4 2025 and held it in 3 quarters.
  • De Lisle Partners's Nephros position peaked at $122K in Q4 2025.
  • 36 funds tracked by Wall St. Rank held Nephros as of Q3 2026.

Based on De Lisle Partners's 13F filing for Q3 2026, filed 13 Nov 2026.